216 related articles for article (PubMed ID: 31371323)
1. A Single-Cell Window into Pancreas Cancer Fibroblast Heterogeneity.
Belle JI; DeNardo DG
Cancer Discov; 2019 Aug; 9(8):1001-1002. PubMed ID: 31371323
[TBL] [Abstract][Full Text] [Related]
2. A Presynaptic Protein Is a Net Gain for Pancreatic Tumor Progression.
Sherman MH
Cancer Discov; 2021 Feb; 11(2):230-232. PubMed ID: 33531426
[TBL] [Abstract][Full Text] [Related]
3. Two Birds with One Stone: Therapeutic Targeting of IL1α Signaling Pathways in Pancreatic Ductal Adenocarcinoma and the Cancer-Associated Fibroblasts.
Ling J; Chiao PJ
Cancer Discov; 2019 Feb; 9(2):173-175. PubMed ID: 30737215
[TBL] [Abstract][Full Text] [Related]
4. The Few yet Fab
Cukierman E
Cancer Discov; 2022 Feb; 12(2):296-298. PubMed ID: 35140177
[TBL] [Abstract][Full Text] [Related]
5. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
[TBL] [Abstract][Full Text] [Related]
6. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity.
Hutton C; Heider F; Blanco-Gomez A; Banyard A; Kononov A; Zhang X; Karim S; Paulus-Hock V; Watt D; Steele N; Kemp S; Hogg EKJ; Kelly J; Jackstadt RF; Lopes F; Menotti M; Chisholm L; Lamarca A; Valle J; Sansom OJ; Springer C; Malliri A; Marais R; Pasca di Magliano M; Zelenay S; Morton JP; Jørgensen C
Cancer Cell; 2021 Sep; 39(9):1227-1244.e20. PubMed ID: 34297917
[TBL] [Abstract][Full Text] [Related]
7. Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation.
Xiao Q; Zhou D; Rucki AA; Williams J; Zhou J; Mo G; Murphy A; Fujiwara K; Kleponis J; Salman B; Wolfgang CL; Anders RA; Zheng S; Jaffee EM; Zheng L
Cancer Res; 2016 Sep; 76(18):5395-404. PubMed ID: 27496707
[TBL] [Abstract][Full Text] [Related]
8. The role of stromal cancer-associated fibroblasts in pancreatic cancer.
von Ahrens D; Bhagat TD; Nagrath D; Maitra A; Verma A
J Hematol Oncol; 2017 Mar; 10(1):76. PubMed ID: 28351381
[TBL] [Abstract][Full Text] [Related]
9. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Park H; Lee Y; Lee H; Kim JW; Hwang JH; Kim J; Yoon YS; Han HS; Kim H
Tumour Biol; 2017 Oct; 39(10):1010428317718403. PubMed ID: 29025374
[TBL] [Abstract][Full Text] [Related]
11. Unlocking the Role of Age-Related Changes to Fibroblasts in Pancreatic Cancer.
Isaacson A; Barki D; Scherz-Shouval R
Cancer Res; 2024 Apr; 84(8):1185-1187. PubMed ID: 38616657
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Fibroblast Heterogeneity: From Development to Cancer.
Garcia PE; Scales MK; Allen BL; Pasca di Magliano M
Cells; 2020 Nov; 9(11):. PubMed ID: 33198201
[TBL] [Abstract][Full Text] [Related]
13. CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression.
Zheng B; Ohuchida K; Chijiiwa Y; Zhao M; Mizuuchi Y; Cui L; Horioka K; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M; Tanaka M
Mol Carcinog; 2016 Nov; 55(11):1560-1572. PubMed ID: 26373617
[TBL] [Abstract][Full Text] [Related]
14. The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance.
Fearon DT
Cancer Immunol Res; 2014 Mar; 2(3):187-93. PubMed ID: 24778314
[TBL] [Abstract][Full Text] [Related]
15. A bird's eye view of fibroblast heterogeneity: A pan-disease, pan-cancer perspective.
Pradhan RN; Krishnamurty AT; Fletcher AL; Turley SJ; Müller S
Immunol Rev; 2021 Jul; 302(1):299-320. PubMed ID: 34164824
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.
Walter K; Omura N; Hong SM; Griffith M; Vincent A; Borges M; Goggins M
Clin Cancer Res; 2010 Mar; 16(6):1781-9. PubMed ID: 20215540
[TBL] [Abstract][Full Text] [Related]
17. Morphological heterogeneity in ductal adenocarcinoma of the pancreas - Does it matter?
Verbeke C
Pancreatology; 2016; 16(3):295-301. PubMed ID: 26924665
[TBL] [Abstract][Full Text] [Related]
18. The Golgi: Keeping It Unapologetically Basic.
Ward NP; DeNicola GM
Cancer Discov; 2020 Jun; 10(6):768-770. PubMed ID: 32482665
[TBL] [Abstract][Full Text] [Related]
19. [Advances in immunotherapy of pancreatic ductal adenocarcinoma].
Yang JQ; Wei T; Chen YW; Bai XL; Liang TB
Zhonghua Wai Ke Za Zhi; 2017 May; 55(5):396-400. PubMed ID: 28464583
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.
Leca J; Martinez S; Lac S; Nigri J; Secq V; Rubis M; Bressy C; Sergé A; Lavaut MN; Dusetti N; Loncle C; Roques J; Pietrasz D; Bousquet C; Garcia S; Granjeaud S; Ouaissi M; Bachet JB; Brun C; Iovanna JL; Zimmermann P; Vasseur S; Tomasini R
J Clin Invest; 2016 Nov; 126(11):4140-4156. PubMed ID: 27701147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
